Invesco Ltd. Rapt Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 11,641 shares of RAPT stock, worth $12,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,641

Previous 12,130 4.03%

Holding current value

$12,921

Previous $36,000 36.11%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1.76 - $3.75 $860 - $1,833	-489 Reduced 4.03%	11,641 $23,000
Q2 2024 Aug 13, 2024	SELL	$2.89 - $9.38 $4,034 - $13,094	-1,396 Reduced 10.32%	12,130 $36,000
Q1 2024 May 14, 2024	SELL	$6.87 - $26.45 $354,711 - $1.37 Million	-51,632 Reduced 79.24%	13,526 $121,000
Q4 2023 Feb 12, 2024	BUY	$11.28 - $25.46 $450,128 - $1.02 Million	39,905 Added 158.02%	65,158 $1.62 Million
Q3 2023 Nov 13, 2023	BUY	$16.34 - $24.66 $184,919 - $279,077	11,317 Added 81.21%	25,253 $419,000
Q2 2023 Aug 11, 2023	SELL	$16.06 - $21.61 $19,079 - $25,672	-1,188 Reduced 7.86%	13,936 $260,000
Q1 2023 May 12, 2023	BUY	$17.19 - $30.8 $259,981 - $465,819	15,124 New	15,124 $277,000
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $2.78 Million - $4.72 Million	154,934 New	154,934 $3.73 Million
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $97,705 - $224,647	-9,523 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$17.02 - $40.22 $902 - $2,131	53 Added 0.56%	9,523 $209,000
Q4 2021 Feb 14, 2022	SELL	$29.5 - $39.5 $1.44 Million - $1.93 Million	-48,834 Reduced 83.76%	9,470 $348,000
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $1.51 Million - $1.99 Million	50,520 Added 649.02%	58,304 $1.81 Million
Q2 2021 Aug 17, 2021	BUY	$17.99 - $40.02 $140,034 - $311,515	7,784 New	7,784 $247,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $32.9M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account